Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) EPS (Basic): 2019-2025

Historic EPS (Basic) for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $0.29.

  • CureVac N.V's EPS (Basic) fell 14.59% to $0.29 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.03, marking a year-over-year increase of 268.94%. This contributed to the annual value of $0.77 for FY2024, which is 160.60% up from last year.
  • According to the latest figures from Q2 2025, CureVac N.V's EPS (Basic) is $0.29, which was up 21.65% from $0.24 recorded in Q1 2025.
  • CureVac N.V's 5-year EPS (Basic) high stood at $1.97 for Q3 2024, and its period low was -$5.06 during Q4 2021.
  • In the last 3 years, CureVac N.V's EPS (Basic) had a median value of $0.29 in 2023 and averaged $0.14.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 1,046.18% in 2021, then soared by 724.06% in 2024.
  • Over the past 5 years, CureVac N.V's EPS (Basic) (Quarterly) stood at -$5.06 in 2021, then soared by 60.45% to -$2.00 in 2022, then fell by 6.00% to -$2.12 in 2023, then spiked by 77.13% to -$0.48 in 2024, then fell by 14.59% to $0.29 in 2025.
  • Its EPS (Basic) stands at $0.29 for Q2 2025, versus $0.24 for Q1 2025 and -$0.48 for Q4 2024.